After accepting chemotherapy, reduced mortality in the GEM+cordycepin group indicated that blocking MMP-3 can suppress gemcitabine resistance and increase mice's tolerance to drugs in DM animal models. The gene discussed is MMP3; the disease is diabetes mellitus.